EPI vs XBI
WisdomTree India Earnings Fund vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.84% for EPI.
- • XBI pays a higher dividend yield (0.36%).
Side-by-side metrics
| Metric | EPI | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.84% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $2.12B | $10.73B |
YTD return | -9.01% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.59 | 1.10 |
P/E ratio | 16.75 | — |
Last price | $42.40 | $164.01 |
Inception | — | — |
Issuer | WisdomTree | State Street |
EPI top holdings
| RELIANCE.NS | Reliance Industries Ltd | 6.59% |
| ICICIBANK.NS | ICICI Bank Ltd | 5.38% |
| HDFCBANK.NS | HDFC Bank Ltd | 5.01% |
| SBIN.NS | State Bank of India | 2.99% |
| COALINDIA.NS | Coal India Ltd | 2.71% |
| 500312 | Oil & Natural Gas Corp Ltd | 2.57% |
| INFY.NS | Infosys Ltd | 2.50% |
| HINDALCO.NS | Hindalco Industries Ltd | 2.36% |
| NTPC.BO | NTPC Ltd | 2.17% |
| POWERGRID.BO | Power Grid Corp Of India Ltd | 2.01% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About EPI
EPI (WisdomTree India Earnings Fund) is Indian companies weighted by earnings. Managed by WisdomTree, the fund carries $2.1B in assets under management, an expense ratio of 0.84%. Its largest holding is Reliance Industries Ltd (RELIANCE.NS), which represents 6.6% of the portfolio. Real Estate is the fund's largest sector exposure at 0.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.